Identification |
Name: | 1H-Pyrido[3,4-b]indole-3-carboxylicacid, 2,3,4,9-tetrahydro-1-methyl- |
Synonyms: | 1,2,3,4-Tetrahydro-3-carboxyharmane;1-Methyl-1,2,3,4-Tetrahydropyrido[3,4-b]indole-3-carboxylic acid;1-Methyl-1,2,3,4-tetrahydro-b-carboline-3-carboxylic acid; NSC 26225; Tetrahydroharman-3-carboxylicacid |
CAS: | 5470-37-1 |
Molecular Formula: | C13H14 N2 O2 |
Molecular Weight: | 230.27 |
InChI: | InChI=1/C23H19N5O2S/c1-15-11-21-26-27-23(28(21)19-10-6-5-9-17(15)19)31-14-20(29)18(12-24)22(30)25-13-16-7-3-2-4-8-16/h2-11,25,30H,13-14H2,1H3 |
Molecular Structure: |
|
Properties |
Transport: | 1544 |
Flash Point: | 248.9°C |
Boiling Point: | 488°Cat760mmHg |
Density: | 1.301g/cm3 |
Refractive index: | 1.697 |
Specification: |
The compounds of the present invention which lack an element of symmetry exist as optical antipodes and as the racemic forms thereof. The optical antipodes may be prepared from the corresponding racemic forms by standard optical resolution techniques, involving, for example, the separation of diastereomeric salts of those instant compounds characterized by the presence of a basic amino group and an optically active acid, or by the synthesis from optically active precursors.
|
Packinggroup: | III |
Flash Point: | 248.9°C |
Storage Temperature: | −20°C |
Safety Data |
|
|